Major histocompatibility complex (MHC) alleles have been recognized as genetic factors for developing systemic lupus erythematosus (SLE). In the present study we analyzed whether a heat-shock protein gene (HSP70-2) is involved in determining susceptibility to develop SLE in a Mexican Mestizo population. A HSP70-2 Pst I polymorphism was detected by a restriction fragment length polymorphism analysis of polymerase chain reaction (PCR-RFLP) in 107 SLE patients and 158 healthy controls. No statistically significant differences were observed in the HSP70-2 allele distribution between patients and healthy controls. HLA-DR analysis showed an increased frequency of HLA-DR3 allele in the patients group (P Ͻ 0.05, OR = 2.26, EF = 6.0%). On the other hand, when we analyzed HSP70-2 polymorphism in relation to HLA-DR3 allele, we could only detect an increased frequency of AB genotype in the DR3 negative patients (pC Ͻ 0.05, RR = 2.6, EF = 11.3%). Linkage disequilibrium was observed for three haplotypes: HLA-DR3- HSP70 
Introduction
Systemic lupus erythematosus (SLE) is an autoimmune disorder in which the genetic factors play an important role. Some major histocompatibility complex (MHC) genes have been associated with susceptibility to develop SLE. Among these HLA-B8, DR2, DR3, homozygous C4 and C4A and/or C4B deficiency, 1 are potential susceptibility loci. The mechanism by which these genes determine susceptibility is not completely understood. However, the hypothesis of unknown susceptibility genes in linkage disequilibrium with those currently detected is being suggested. Thus, other MHC genes detected in the class III region have been studied. 2 The heat-shock protein (HSP70-2) gene, encodes a highly inducible stress protein fundamentally important for protein transport and folding. 3 Several studies have proposed the HSP's loci as possible susceptibility genes for the development of autoimmune diseases; ie, Grave's disease, 4 insulindependent diabetes mellitus, 5 celiac disease 6 and SLE. 7, 8 In Spanish patients with SLE, the association was due to linkage disequilibrium between HSP70 and HLA-DR3, 7 whereas in African American patients the association was independent of this disequilibrium. 8 Since the linkage disequilibrium between HLA and HSP70-2 alleles has been described in Caucasian populations, studies in other populations are mandatory. To expand the knowledge of this association, we have investigated by polymerase chain reaction (PCR) and restriction fragment length polymorphism (RFLP) analysis, the distribution of the HSP70-2 alleles in Mexican Mestizo SLE patients. Table 1 summarizes the HSP70-2 genotype and allele frequencies of 107 SLE patients and 158 controls. In both groups, the most common genotype was heterozygous AB (83.1% in patients and 72.2% in controls) and the most frequent allele was A (58.4% in patients and 58.9% in controls). The BB homozygous individuals were only detected in the control group and showed an increased frequency when compared with patients (5%, pC Ͻ 0.05 vs patients). No statistically significant differences were observed when the HSP70-2 alleles distribution between patients and healthy controls was compared. Complete analysis of HLA-DR alleles in Mexican patients and controls showed an increased frequency of HLA-DR3 (P Ͻ 0.05, pC = NS, OR = 2.26, EF = 6.0%) and decreased frequencies of HLA-DR7 (P Ͻ 0.05, pC = NS) and HLA-DR8 (P Ͻ 0.05, pC = NS) alleles in the patient's group (Table 2) . Because the HLA-DR3 is in strong linkage disequilibrium with the HSP70 alleles, we analyzed HSP70-2 polymorphism in relation to HLA-DR3 in 107 patients (20 positives and 87 negatives for DRB1*03) and 78 controls (six The P values were corrected by multiplying them by the number of comparisons. *pC Ͻ 0.05. positives and 72 negatives for DRB1*03) ( Table 3) . In this case, we did not find significant differences in the HSP70-2 alleles distribution between SLE patients and controls. An increased frequency of AB genotype was observed in the DR3 negative patient's group (81.6% in patients vs 62.5% in controls, pC Ͻ 0.05, RR = 2.6, EF = 11.3%). Linkage disequilibrium between HSP70-2 and HLA-DR alleles was noted: 
Results

Discussion
SLE is an autoimmune disorder with a large spectrum of clinical manifestations and a variety of immunological features. In Mexican Mestizo patients the disease has been associated principally with the HLA-DR3 allele. 9 However, other susceptibility genes could be located either close by or outside of the HLA class II region. The chromosomal mapping of the three members of the HSP70 gene family in the HLA class III region 10 and their linkage disequilibrium with other relevant HLA genes 6 has led to investigation of the possible role of HSP70 genes in the genetic susceptibility to autoimmune diseases. Our results suggest that there is no significant association of HSP70-2B allele with the susceptibility to develop SLE. The presence of BB homozygous individuals in the control group could only reflect HSP70-2B allele linkage disequilibrium with some frequent HLA alleles in this group. The present results do not support the findings in previous studies which have implicated HSP70-2 gene polymorphism in SLE and other autoimmune diseases. [4] [5] [6] [7] [8] However, in most of the cases, the associations were due to linkage disequilibrium between HSP70-2B and DR3 alleles [5] [6] [7] which are included in the A1-B8-DR3 and A30-B18-DR3 extended haplotypes and thus, probably secondary to, the DR/DQ associations.
On the other hand, previous studies have failed to show significant relevance of HSP70 polymorphism in the susceptibility to several HLA-associated diseases.
11,12
The HSP70-2 polymorphism analysis, together with a previous one in which no association was observed This analysis included 78 controls typed for HLA-DR and HSP70-2. None of them were BB homozygous. The P values were corrected by multiplying them by the number of comparisons. **,*pC Ͻ 0.05. In the patients group, 20 individuals were DR3 positives: 19 were DRB1*0301 and one was DRB1*0302, whereas in the control group only six were DR3 positives: four were DRB1*0301, one was DRB1*0302 and one was DRB1*0303.
between HSP70-1 polymorphism and SLE, 13 appears to rule out the relevance of the HSP70 locus in the susceptibility to develop SLE.
The mechanism by which the HSP70 genes could determine the susceptibility to SLE and other autoimmune diseases is largely unknown. Recent information in rheumatoid arthritis 14 suggests that HLA-DR4 and DR10 motifs associated with the disease bind a 70 Kb heat-shock protein. This could influence the processing of antigenic peptides and their inclusion in the HLA-DRB1 chain groove. However, this would be expected in the case of HSP70-hom variation which lies within the predicted peptidebinding domain, 15 but not in the case of HSP70-2 in which polymorphism depends only on a silent change (A→G) in the coding region. Thus, any contribution of the HSP70-2 polymorphism to SLE susceptibility could be attributed to a neighboring gene yet unidentified.
In conclusion, our results appear to rule out any relevance of the HSP70-2 locus in the susceptibility to SLE in Mexican Mestizo individuals.
Material and methods
Sample
One-hundred and seven unrelated Mexican Mestizo patients with SLE, who fulfilled the American College of Rheumatology criteria, were studied. As controls, 158 healthy Mexican Mestizo individuals, without a case history of connective tissue disorders, were included (HSP70-2 polymorphism for this group has been published previously). 16 We considered Mexican Mestizo those individuals whose last two generations were born in Mexico. This group is genetically well characterized and has shown a proportion of 56% Indian genes, 40% of Caucasian genes and 4% of Black genes. [17] [18] [19] DNA extraction Genomic DNA from whole blood containing EDTA was extracted by standard techniques.
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Generic HLA-DR typing Generic DR typing was performed by PCR-SSO reverse dot blot using the Amplicor Kit (Hoffmann La Roche, Basel, Switzerland).
Typing for DR3 alleles
Subtypes of DR3 specificity were detected by a direct sequence strategy. DNA of each individual (patient or control) that was positive for DR3, was amplified using the primers: DRBAMP-B (5Ј-CCGCTGCACTGTGAAG CTCT-3Ј) and DRBAMP-3 (5Ј-CACGTTTCTTGGAG TACTCTAC-3Ј). Templates were purified using Qiaquick Gel Extraction Kit (QIAGEN, Hilden, Germany) and sequenced by the Sanger dideoxy chain terminator method, with dye-labeled dideoxy terminator chemistry. DNA samples were analyzed in a Perkin-Elmer 310 automated DNA sequencer (Applied Biosystems, CA, USA).
PCR analysis of HSP70-2 alleles
A HSP70-2 restriction fragment length polymorphism at position 1267 was characterized by a PCR procedure. 7 This analysis was performed considering the polymorphic Pst I site at position 1267 of these alleles. We selected the following primers spanning the polymorphic Pst I site Genes and Immunity (nucleotide 1267) according to the previously described sequence, 7 sense (nucleotide 1083-1102 within the coding region) 5Ј-CATCGACTTCTACACGTCCA-3Ј and antisense (nucleotide 2180-2199 within the 3Ј untranslated end to avoid HSP70-1 homology) 5Ј-CAAAGTCC TTGAGTCCCAAC-3Ј. Genomic DNA from peripheral blood leukocytes of patients and controls was amplified under the following conditions: 200 m each dNTP, 2 mm MgCl 2 , 1X PCR buffer, 25 pmol of each primer and 1 unit of Taq DNA polymerase (Promega, Madison, WI, USA) in 25 l of reaction. The PCR was carried out by 35 cycles of denaturing at 94°C for 1 min., annealing at 56°C for 1 min., and extension at 72°C for 2 min. The products of PCR were cleaved with Pst I (Pharmacia, Uppsala, Sweden) and electrophoresced on ethidium bromidestained 1.5% agarose. The DNA lacking polymorphic Pst I site within the HSP70-2 gene generates a product of 1117 bp after restriction (allele A), whereas the Pst I site produced two fragments of 936 and 181 bp (allele B).
Statistical analysis
Significance in genotype and allele frequencies was analyzed by using contingency 2×2 tables and the chi-square test. The P values were corrected by the Bonferroni method multiplying the P values for the number of comparisons. The strength of the association was estimated by the relative risk (RR) and etiologic fraction (EF). 
